2019 Conditions Epilepsy Safety 
Peninsula Alternative Health
MAY 15, 2019
As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because cannabis is still a schedule 1 drug in the U.S.,
Cannabis Law Report
AUGUST 10, 2021
GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. TSC is typically diagnosed in childhood. (5)
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Peninsula Alternative Health
MAY 15, 2019
As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because cannabis is still a schedule 1 drug in the U.S.,
The Cannigma
APRIL 19, 2021
In recent years, lawmakers have eased up on a number of cannabis-derived formulations, and since 2015, people with epilepsy can obtain cannabis oil that contains less than 0.5% These products can be prescribed to a resident of the state by a medical physician that is qualified “with respect to a patient’s particular medical condition.”.
Veriheal
NOVEMBER 18, 2022
According to the Texas Department of Public Safety Chief Wayne Muller, the state has averaged a 10% month-over-month increase in medical cannabis patients over the last 18 months. In September, the state expanded its list of qualifying conditions , allowing veterans with PTSD and cancer patients to join the program.
MMJ Recs
DECEMBER 13, 2023
However, the tide began to turn in 2015 when the state legislature passed the Compassionate Use Act, allowing for the limited use of low-THC cannabis for patients with intractable epilepsy. Qualifying conditions include epilepsy, terminal cancer, multiple sclerosis, autism, and incurable neurodegenerative diseases.
Dykema (Cannabis Law Blog)
APRIL 20, 2023
[iii] The Act was originally intended for patients with intractable epilepsy and was expanded in 2019 and 2021 to include other physical and mental illnesses (cancer, multiple sclerosis, post-traumatic stress disorder). [iv] Health & Safety Code § 487.001 et seq. [iv] Specifically, H.B. Specifically, H.B. 1805, 88th Leg.,
Expert insights. Personalized for you.
89 
Let's personalize your content